Clinical Trial Update: The BeLimumab Antiphospholipid Syndrome Trial (BLAST) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for the BeLimumab antiphospholipid syndrome study (BLAST) covering Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: University of Turin, Italy | Conditions: Antiphospholipid Syndrome | Phase 2, Phase 3 | Status: UNKNOWN